Charles Sawyers and colleagues have conducted a small early-stage clinical study to assess target modulation by the small-molecule inhibitor rapamycin. Rapamycin is approved to treat renal cancer ...

Rapamycin, a natural compound, has shown anti-aging and health benefits in various researches. Consequently, the popularity and demand for rapamycin supplements have surged significantly in the ...

Rapamycin is a drug used to suppress the immune system in transplant patients, but scientists have found that it may have ...

Researchers say study findings have important implications for our understanding of the pathogenesis of obesity and potential therapeutic applications.

But out of all the supplements and drugs he takes for 'living healthy forever', one key medicine that Bryan and other ...

As the researchers describe in a new paper in Cell Metabolism, the drug rapamycin restores leptin sensitivity to diet-induced obese mice, leading to significant loss of fat with only minimal effects ...

Rapamycin is used to prevent graft rejection in transplant recipients based on its ability to suppress T-cell proliferation. The drug blocks the activity of a protein known as mammalian target of ...

Quoin Pharmaceuticals (QNRX) announced it has filed U.S. and International patent applications for novel topical rapamycin formulations as ...

Target Indications Include Microcystic Lymphatic Malformations, Venous Malformations and AngiofibromasProprietary Invisicare Delivery Technology ...

Jeffrey Friedman and Kristina Hedbacker, research associate, were first authors, as was Bowen Tan (pictured below). (Credit: Lori Chertoff/The ...

A transformative study has uncovered the pivotal role of the protein Naked cuticle homolog 2 (NKD2) in regulating the differentiation of bone-forming osteoblasts and bone-resorbing osteoclasts.

17/391.495 titled “Oral Rapamycin Nanoparticle Preparations and Use” which was exclusively licensed to Biodexa by Rapamycin Holdings, Inc. d/b/a Emtora Biosciences, along with other patents ...